AdvanSix (NYSE:ASIX) Releases Earnings Results

AdvanSix (NYSE:ASIX) released its quarterly earnings data on Friday. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.37), FiscalAI reports. The firm had revenue of $421.28 million during the quarter, compared to analysts’ expectations of $452.00 million. AdvanSix had a net margin of 0.67% and a return on equity of 2.18%.

Here are the key takeaways from AdvanSix’s conference call:

• Second-quarter results improved sequentially but declined year over year: Sales rose 3% to $421 million, while adjusted EBITDA fell to $32 million and adjusted EPS declined to $0.19, primarily due to lower volumes and agricultural weakness.
• Strong commercial execution fully offset a $72 million year-over-year raw-material cost headwind, with pricing across Plant Nutrients, Chemical Intermediates, and Nylon Solutions recovering higher benzene, sulfur, and propylene costs.
• Plant Nutrients volumes were below expectations as elevated grower input costs and weak crop economics reduced fertilizer consumption; management expects a larger-than-usual sequential earnings headwind from the fall fertilizer reset due to high sulfur prices and channel inventory.
• Management expects significant second-half improvement in earnings and cash flow, supported by completed turnaround work, lower capital expenditures, working-capital tailwinds, cost reductions, and an anticipated $18 million Section 45Q tax-credit payment in the second half.
• AdvanSix is expanding optionality around its integrated ammonia platform, targeting a 30% increase in 2026 ammonia sales volume, pursuing a potentially 50%-funded USDA ammonia-capacity grant, and progressing its DEF project toward a 2027 investment decision.

AdvanSix Trading Down 17.9%

Shares of NYSE:ASIX traded down $3.61 on Friday, hitting $16.53. The company had a trading volume of 718,970 shares, compared to its average volume of 218,346. The firm’s 50-day simple moving average is $20.64 and its two-hundred day simple moving average is $20.79. AdvanSix has a 1 year low of $14.10 and a 1 year high of $26.73. The company has a quick ratio of 0.68, a current ratio of 1.23 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of $445.54 million, a price-to-earnings ratio of 44.67 and a beta of 1.29.

AdvanSix Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Tuesday, August 18th will be issued a $0.16 dividend. The ex-dividend date is Tuesday, August 18th. This represents a $0.64 annualized dividend and a yield of 3.9%. AdvanSix’s dividend payout ratio is 172.97%.

Key Stories Impacting AdvanSix

Here are the key news stories impacting AdvanSix this week:

• Positive Sentiment: AdvanSix maintained its quarterly dividend at $0.16 per share. The payment is scheduled for September 1 for shareholders of record on August 18, representing an annualized yield of approximately 3.9%. AdvanSix Posts Mixed Q2 Results, Maintains Dividend Payout
• Neutral Sentiment: Management’s second-quarter earnings call and presentation provided additional detail on the results and outlook, but the available reports characterize the quarter as mixed rather than indicating a clear improvement in near-term fundamentals. AdvanSix Q2 2026 Earnings Call Transcript
• Negative Sentiment: AdvanSix reported second-quarter revenue of approximately $421.3 million, below the $452 million analyst consensus, while EPS of $0.19 missed expectations of $0.56 by $0.37. The company’s net margin was only 0.67% and return on equity was 2.18%, highlighting weak profitability. AdvanSix Q2 Earnings Snapshot
• Negative Sentiment: Wall Street Zen downgraded ASIX to “Sell,” adding to the negative reaction to the earnings miss. Shares are trading below both their 50-day and 200-day moving averages, while elevated trading volume suggests heightened investor concern. AdvanSix Cut to Sell at Wall Street Zen

Hedge Funds Weigh In On AdvanSix

Hedge funds and other institutional investors have recently modified their holdings of the stock. Osaic Holdings Inc. lifted its position in AdvanSix by 60.2% during the second quarter. Osaic Holdings Inc. now owns 1,285 shares of the company’s stock valued at $31,000 after purchasing an additional 483 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in AdvanSix by 4.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,147 shares of the company’s stock worth $343,000 after buying an additional 604 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of AdvanSix by 8.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,862 shares of the company’s stock worth $234,000 after buying an additional 746 shares during the period. Mariner LLC raised its stake in shares of AdvanSix by 10.2% in the fourth quarter. Mariner LLC now owns 11,065 shares of the company’s stock worth $191,000 after buying an additional 1,023 shares during the period. Finally, Raymond James Financial Inc. purchased a new position in shares of AdvanSix during the 2nd quarter valued at about $29,000. Hedge funds and other institutional investors own 86.39% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on ASIX. Zacks Research raised AdvanSix to a “hold” rating in a research note on Tuesday, May 12th. Weiss Ratings lowered AdvanSix from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, May 13th. Finally, Wall Street Zen cut AdvanSix from a “hold” rating to a “sell” rating in a report on Saturday. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average target price of $22.50.

AdvanSix Company Profile

AdvanSix, Inc (NYSE: ASIX) is an integrated chemical manufacturer specializing in the production of nylon 6 intermediates and related co?products. Established as a publicly traded spin?off from Honeywell Specialty Chemicals in June 2016, the company is headquartered in Parsippany, New Jersey.

The company’s principal product is caprolactam, the key building block for nylon 6 resin, used in fibers and engineering plastics across industries. In addition to caprolactam and nylon 6 resin, AdvanSix produces ammonium sulfate fertilizer and industrial chemicals such as phenol and acetone.